Physician profile
Javid Iqbal
NPI 1710941414
$1,789.53
in general payments reported to CMS, 2019-2025
16 companies · $261 in 2025
The $261 reported for 2025 was more than what 81% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $40.79 · 2021: $62.46 · 2022: $160 · 2023: $410 · 2024: $380 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $379.11 | 2019-2024 | Eliquis |
| Abbvie INC. | $366.39 | 2021-2025 | |
| Pfizer INC. | $346.97 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $219.07 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $120.17 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Janssen Pharmaceuticals, INC | $118.21 | 2019-2024 | Xarelto |
| Philips North America LLC | $56.00 | 2022-2024 | (Ak6) Vest Therapy |
| Portola Pharmaceuticals, LLC | $27.99 | 2019 | |
| Melinta Therapeutics, LLC | $27.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.64 | 2019 | |
| Viatris Specialty LLC | $23.76 | 2025 | Yupelri |
| Smith+Nephew, INC. | $17.78 | 2023 | Collagenase Santyl |
| Baxter Healthcare | $16.62 | 2023 | Starling System |
| Allergan, INC. | $15.37 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.93 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javid Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.